Pulmonary hypertension (PH) is a complex and progressive disease characterized by elevated pulmonary arterial pressure and pulmonary vascular resistance. It is essential for healthcare professionals to understand its fundamentals to facilitate timely diagnosis and effective management.
PH involves the narrowing of the pulmonary arteries, leading to increased resistance to blood flow. This results in the right ventricle working harder to pump blood, leading to right heart failure if untreated. The precise pathophysiology varies with the type of PH, but often involves endothelial dysfunction, vasoconstriction, and vascular remodeling.
The World Health Organization (WHO) classifies PH into five groups based on etiology, clinical presentation, and hemodynamic characteristics. Diagnosis requires a high index of suspicion and is confirmed through right heart catheterization. Echocardiography serves as a crucial non-invasive screening tool.
Treatment strategies for PH are multifaceted and should be tailored to the individual patient. They include general measures, supportive treatments, and specific drug therapies. The choice of therapy depends on the WHO group of PH, the patient's functional class, and the risk stratification.
Despite advances in therapy, PH remains a disease with a significant morbidity and mortality rate. Regular follow-up with right heart catheterization and echocardiography is necessary to assess disease progression and response to therapy. Early referral to a specialized center is recommended for complex cases.
Understanding the fundamentals of PH is crucial for healthcare professionals. It allows for prompt diagnosis, effective management, and improved patient outcomes. As PH is a rapidly evolving field, staying updated with the latest research and treatment guidelines is essential.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation